Viromed Medical AG (XTER:VME) Current Accrued Expense: € Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:VME Viromed Medical AG XTER:VME
22 GF Score
Price €5.65
! 2 Warning Signs
View Full Analysis

What is Viromed Medical AG Current Accrued Expense?

Viromed Medical AG XTER:VME -1.77% 22 Current Accrued Expense is € Mil as of Dec. 2025. GuruFocus rates XTER:VME with a GF Score™ of 22/100. The stock has 2 warning signs investors should review.

Viromed Medical AG's Current Accrued Expense for the quarter that ended in Dec. 2025 was € Mil.

Viromed Medical AG's quarterly Current Accrued Expense increased from Dec. 2024 (€ Mil) to Jun. 2025 (€0.02 Mil) but then declined from Jun. 2025 (€0.02 Mil) to Dec. 2025 (€ Mil).

Viromed Medical AG Current Accrued Expense Related Terms

Viromed Medical AG Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Viromed Medical AG's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viromed Medical AG Current Accrued Expense Chart

Viromed Medical AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
- - - - -

Viromed Medical AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Current Accrued Expense Get a 7-Day Free Trial - - - 0.02 -
XTER:VME
22GF Score
Viromed Medical AG XTER:VME
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viromed Medical AG Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of € Mil mean?
Viromed Medical AG (XTER:VME) has a Current Accrued Expense of € Mil as of Dec. 2025. Current Accrued Expense records the total amount of accrued expenses. View historical data on Viromed Medical AG and its competitors.
Is Viromed Medical AG's Current Accrued Expense too high?
Viromed Medical AG's current Current Accrued Expense is € Mil. Overall, Viromed Medical AG has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Viromed Medical AG's Current Accrued Expense compare to ABT and SYK?
Viromed Medical AG's Current Accrued Expense of € Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Devices & Instruments company?
A good Current Accrued Expense depends on the Medical Devices & Instruments industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Viromed Medical AG and its competitors. Viromed Medical AG's current Current Accrued Expense is € Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viromed Medical AG stock overvalued right now?
Viromed Medical AG (XTER:VME) has a current Current Accrued Expense of € Mil. The current Current Accrued Expense is € Mil. Viromed Medical AG's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Viromed Medical AG (XTER:VME), the current Current Accrued Expense is € Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Viromed Medical AG Business Description

Other Exchanges VME:GermanyVME:Germany
Address Hauptstrasse 105, Rellingen, Pinneberg, SH, DEU, 25462
Viromed Medical AG is a medical technology company. It focuses on using cold plasma technology to develop medical solutions that protect people from viruses, bacteria, and multi-resistant germs. Viromed's product offerings include ViroCAP, a medical device based on cold plasma technology for treating wounds; ViroCAP derma-podo, a medical device that uses cold atmospheric plasma therapy for skin and foot care; and a Raumluftentkeimer. The company covers the entire value chain from research and development to production, logistics, marketing, and sales of its products.
22GF Score

Get the complete analysis for XTER:VME

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.65
Price